Member Info for MrRSoul

4.3996 (up 6.01%)

Make of it what you will but it don't make sense!

Oh No....Not FFF aka Fat Finger Flora!

4.052 (2.36%)

Juxtaposition

How can you tell?

OTM

Right again.If only....................

Just a thought, it may help others if you make a list of ALL the things and predictions you have been right about so far!

Patience one and all. Frustrating as it is, I and others on here still believe ImmuPharma will secure the best deal they can.

Ogm4

AI will have something to say about that.

The times are fast achanging!

Keep the faith and spread the word F laura

Keep the faith Revd cos I had a good laugh catching up on the posts .

flora-margarine-advert-from-the-1970s

Turn the other cheek.

Peace on them.

Oscar22

Is this not a repeat post frm this morning ?

I did read it honest.

What have I missed ?

Seems a lot of hype with no real or new information unless someone can tell me different!

In the words of the Scousers 'Calm Down Calm Down'.

The Revd delivers a sermon and a reply cometh within a minute!

1-2-Many is not not often wrong but right again!

Suffice to say it will need to be a well respected American company imo.

Hyperthetical question of course BUT I did wonder which of the below companies would be most beneficial to ImmuPharma should Tim and Co have to make a choice.

Johnson & Johnson (JNJ)

Market cap: $553.29 Billion USD

AbbVie

Market cap: $349.11 Billion USD

GSK

Market cap: £80.31 Billion

Time to let the cat out of the bag!

Undervaluedtoday

Todays open letter from Tim ??

If you have copied and pasted these three entries could you tell us where they are from.? Also points 1-6 where are they?

Apologies if I have misunderstood your message but I genuinely don't follow your info!

MM

Your guess is as good as mine.

The whole secrecy surrounding what is or is not going to happen has dragged on so long that there will never be any confidence in any news thats eventually released.

The 'TIM' Team have overplayed their hand and us lot (the mushrooms) have been fed sxxxt and kept in the dark.

However I can't help but feel that one of the big three mentioned or a. n. other that this is too good a deal to ignore.

No doubt the U.S. market will play a major part in the all singing all dancing deal and as soon as I can I will have cashed in my chips and moving on.

But then again what do I know, there are people on here who are convinced they have all the answers and that you should have listened to their advice and analysis months ago.

'One' in particular has been so right on a couple of occasions that I honestly wished I had listened to him and got out with no loss some time ago.

The bottom line....... No-one has a Scooby Do. so GLA and keep the faith at least for a short while longer! DYOR etc.

Based on the projected 2026 landscape of top global pharmaceutical companies—characterized by high R&D spending, a focus on immunology/autoimmune diseases, and the need to replace revenue from patent expirations—

AbbVie,

Johnson & Johnson

GSK are the most likely candidates to be interested in ImmuPharma's P140 (Lupuzor™) platform in 2026

CSPC Pharmaceuticals (that is)

SYN00GOLD

You would expect their share chart to paint a better picture as a result of those facts wouldn't you?